NSE › Healthcare

Dr. Lal Path Labs Ltd. (LALPATHLAB)

NSE · Healthcare · Diagnostics & Research

₹1,900.40-0.25%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹703 cr
Revenue YoY
+16.6%
Net profit
₹131 cr
Profit YoY
-15.2%
EPS
₹8.44
EPS estimate
₹7.42
Net margin
18.7%

EPS came in at 8.44 against a street estimate of 7.42 — a beat of 13.7%.

Key statistics

Market cap
₹31,726 cr
P/E
58.7
Forward P/E
50.3
P/B
12.68
Book value
₹150.21
EPS (TTM)
₹32.39
Dividend yield
0.85%
52-week high
₹990,230.11
52-week low
₹1,266.16
50-day MA
₹1,668.02
200-day MA
₹1,507.34
Beta
0.19

Analyst view

with an average price target of ₹1,920.15.

Shareholding

Promoters
54.90%
Institutions
31.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Dr. Lal Path Labs Ltd. — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.